EBNA2 is required for protection of latently epstein-barr virus-infected B cells against specific apoptotic stimuli

Myun Lee Jae, Kyoung Ho Lee, Christopher J. Farrell, Paul D. Ling, Bettina Kempkes, Han Park Jeon, S. Diane Hayward

Research output: Contribution to journalArticle

Abstract

In addition to functioning as a transcriptional transactivator, Epstein-Barr virus EBNA2 interacts with Nur77 to protect against Nur77-mediated apoptosis. Estrogen-regulated EBNA2 in EREB2-5 cells was replaced by either EBNA2 or EBNA2 with a deletion of conserved region 4 (EBNA2ΔCR4). Both EBNA2-converted and EBNA2ΔCR4-converted EREB2-5 cells grew in the absence of estrogen and expressed LMP1. Treatment with tumor necrosis factor alpha did not induce apoptosis of EBNA2- or EBNA2ΔCR4-expressing cells, but EBNA2ΔCR4 cells were susceptible to etoposide and 5-fluorouracil, Nur77-mediaied inducers of apoptosis. Thus, EBNA2 protects B cells against specific apoptotic agents against which LMP1 is not effective.

Original languageEnglish (US)
Pages (from-to)12694-12697
Number of pages4
JournalJournal of Virology
Volume78
Issue number22
DOIs
Publication statusPublished - Nov 2004

    Fingerprint

ASJC Scopus subject areas

  • Immunology

Cite this

Jae, M. L., Lee, K. H., Farrell, C. J., Ling, P. D., Kempkes, B., Jeon, H. P., & Hayward, S. D. (2004). EBNA2 is required for protection of latently epstein-barr virus-infected B cells against specific apoptotic stimuli. Journal of Virology, 78(22), 12694-12697. https://doi.org/10.1128/JVI.78.22.12694-12697.2004